Raras
Buscar doenças, sintomas, genes...
Síndrome Catel-Manzke
ORPHA:1388CID-10 · Q87.8CID-11 · LD2F.1YOMIM 302380DOENÇA RARA

A síndrome de Catel-Manzke é uma doença óssea rara, caracterizada por um osso a mais e uma curvatura nos dedos indicadores de ambas as mãos. Geralmente, ela aparece associada à sequência de Pierre Robin, que inclui mandíbula pequena, fenda no céu da boca e a língua que cai para trás.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de Catel-Manzke é uma doença óssea rara, caracterizada por um osso a mais e uma curvatura nos dedos indicadores de ambas as mãos. Geralmente, ela aparece associada à sequência de Pierre Robin, que inclui mandíbula pequena, fenda no céu da boca e a língua que cai para trás.

Publicações científicas
32 artigos
Último publicado: 2026 Apr

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
33
pacientes catalogados
Início
Antenatal
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q87.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
16 sintomas
😀
Face
8 sintomas
❤️
Coração
7 sintomas
👁️
Olhos
4 sintomas
📏
Crescimento
3 sintomas
🫃
Digestivo
2 sintomas

+ 18 sintomas em outras categorias

Características mais comuns

90%prev.
Déficit de crescimento
Muito frequente (99-80%)
90%prev.
Anormalidade da morfologia da epífise
Muito frequente (99-80%)
90%prev.
Micrognatia
Muito frequente (99-80%)
90%prev.
Achatamento malar
Muito frequente (99-80%)
90%prev.
Fissura palatina
Muito frequente (99-80%)
90%prev.
Glossoptose
Muito frequente (99-80%)
63sintomas
Muito frequente (7)
Frequente (9)
Ocasional (9)
Sem dados (38)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 63 características clínicas mais associadas, ordenadas por frequência.

Déficit de crescimentoFailure to thrive
Muito frequente (99-80%)90%
Anormalidade da morfologia da epífiseAbnormality of epiphysis morphology
Muito frequente (99-80%)90%
MicrognatiaMicrognathia
Muito frequente (99-80%)90%
Achatamento malarMalar flattening
Muito frequente (99-80%)90%
Fissura palatinaCleft palate
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico32PubMed
Últimos 10 anos16publicações
Pico20153 papers
Linha do tempo
2026Hoje · 2026📈 2015Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

TGDSUDP-D-glucose 4,6-dehydrataseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

UTP-glucose 4,6-dehydratase that converts UDP-glucose into UDP-4-keto-6-deoxyglucose, and which is required for glycosaminoglycan biosynthesis and skeletal development (PubMed:40836090). UDP-4-keto-6-deoxyglucose is a mimic of the reaction intermediate of UXS1 and acts as an enzyme-rescue metabolite to promote the completion of UXS1 catalytic cycle when NAD(+) levels are low (PubMed:40836090). Under low NAD(+) conditions, UXS1 forms an inactive UDP-4-ketoxylose intermediate bound to NADH, impair

LOCALIZAÇÃO

Endoplasmic reticulumGolgi apparatus

MECANISMO DE DOENÇA

Catel-Manzke syndrome

A syndrome characterized by Pierre Robin sequence and a unique form of bilateral hyperphalangy causing a clinodactyly of the index finger. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia).

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
32.2 TPM
Tireoide
19.5 TPM
Cervix Endocervix
19.1 TPM
Ovário
19.0 TPM
Nervo tibial
18.9 TPM
OUTRAS DOENÇAS (1)
Catel-Manzke syndrome
HGNC:20324UniProt:O95455

Variantes genéticas (ClinVar)

102 variantes patogênicas registradas no ClinVar.

🧬 TGDS: GRCh38/hg38 13q31.3-34(chr13:89779269-114338054)x1 ()
🧬 TGDS: NM_014305.4(TGDS):c.983-20C>T ()
🧬 TGDS: GRCh37/hg19 13q31.2-33.1(chr13:88690727-102272954)x1 ()
🧬 TGDS: NM_014305.4(TGDS):c.964G>A (p.Glu322Lys) ()
🧬 TGDS: NM_014305.4(TGDS):c.711TGT[1] (p.Val239del) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 21 variantes classificadas pelo ClinVar.

15
6
Patogênica (71.4%)
VUS (28.6%)
VARIANTES MAIS SIGNIFICATIVAS
TGDS: NM_014305.4(TGDS):c.964G>A (p.Glu322Lys) [Likely pathogenic]
TGDS: NM_014305.4(TGDS):c.711TGT[1] (p.Val239del) [Pathogenic]
TGDS: NM_014305.4(TGDS):c.305C>T (p.Thr102Ile) [Likely pathogenic]
TGDS: NM_014305.4(TGDS):c.457-2A>G [Likely pathogenic]
TGDS: NM_014305.4(TGDS):c.313+1G>A [Likely pathogenic]

Vias biológicas (Reactome)

1 via biológica associada aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Catel-Manzke

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

📖Melhor nível de evidência: Revisão
Timeline de publicações
14 papers (10 anos)
#1

A missing enzyme-rescue metabolite as cause of a rare skeletal dysplasia.

Nature2025 Oct

Living cells depend on an intricate network of chemical reactions catalysed by enzymes, which sometimes make mistakes that lead to their inactivation. Here we report a metabolite-based mechanism for preserving enzyme function in an unfavourable environment. We found that the enzyme TGDS produces UDP-4-keto-6-deoxyglucose, a mimic of the reaction intermediate of the enzyme UXS1, which regenerates the essential cofactor NAD+ within the catalytic pocket of UXS1 by completing its catalytic cycle. Thus, the production of an 'enzyme-rescue metabolite' by TGDS represents a mechanism for maintaining the activity of an enzyme in a subcellular compartment where NAD+ is scarce. Using a combination of in vitro and in vivo studies, we demonstrate that the inability to produce sufficient amounts of this enzyme-rescue metabolite leads to the inactivation of UXS1, impairing the synthesis of specific glycans that are crucial for skeletal development. This provides an explanation for the development of the hereditary skeletal disorder Catel-Manzke syndrome in individuals with TGDS deficiency. Defects in similar protective layers might contribute to metabolic changes in other diseases that cannot be explained with common concepts in metabolic biochemistry.

#2

Zebrafish as a model for Catel-Manzke syndrome-identification and characterization of the zebrafish TGDS ortholog.

The FEBS journal2025 Oct 29

Catel-Manzke syndrome (CMS) is a rare genetic disorder associated with mutations in the TDP-glucose 4,6-dehydratase (TGDS) gene, the function of which in vertebrates remains unclear. This study investigated the zebrafish ortholog tgds to assess its suitability for modeling the disease. During development, the tgds transcript exhibits a conserved biphasic expression pattern with an initial maternal contribution followed by a second wave of expression after gastrulation. Recombinant zebrafish Tgds expressed in Escherichia coli demonstrated UDP-D-glucose 4,6-dehydratase (EC4.2.1.76) activity, similar to TGDS orthologs in lower eukaryotes, where it acts as the first step in the L-rhamnose biosynthetic pathway. This finding suggests the presence of a yet unidentified pathway in vertebrates. Furthermore, CMS-associated mutations in conserved residues significantly impair enzyme activity and stability. CRISPR/Cas9-mediated F0 knockout of tgds resulted in a range of developmental defects in zebrafish. In particular, craniofacial cartilage alterations, associated with a decrease in sulfate glycosaminoglycan content, mirrored some skeletal features observed in humans with CMS. These findings establish the zebrafish as a relevant model to further explore CMS pathogenesis and the in vivo function of tgds.

#3

Functional loss of rffG and rfbB, encoding dTDP-glucose 4,6-dehydratase, alters colony morphology, cell shape, motility and virulence in Salmonella Typhimurium.

Frontiers in microbiology2025

Lipopolysaccharide (LPS) O-antigen and enterobacterial common antigen (ECA) play crucial roles in maintaining the outer membrane in Gram-negative bacteria. Mutations in the biosynthetic pathways of LPS and ECA may lead to accumulation of intermediates, resulting in morphological changes and activation of stress responses. However, the functional consequences of abrogation of both O-antigen and ECA synthesis in Salmonella enterica serovar Typhimurium (S. Typhimurium) are not well investigated. In this study, we generated single and double-deletion mutants of rfbB and rffG, encoding dTDP-glucose 4,6-dehydratase paralogs that are important in the synthesis of both O-antigen and ECA. Importantly, mutations in the dTDP-D-glucose 4,6-dehydratase encoding gene in humans are known to cause Catel-Manzke syndrome, a rare genetic disease. All four strains, i.e., wild type (WT), ΔrfbB, ΔrffG and ΔrfbBΔrffG, grew well in rich Luria Bertani (LB) liquid media at 37°C; however, the functional loss of both rfbB and rffG, but not in single-deletion strains, resulted in round cell morphology and smaller colony size in LB agar plates. There was no significant differences in the growth of the four strains in minimal media at 37°C (nutritional deficiency), in LB at 42°C (high temperature), acidic pH or LB with 3-4% NaCl (high osmolarity; however the ΔrfbBΔrffG strain was hypersensitive to bile and cell wall-targeting antibiotics). These results demonstrated that the ΔrfbBΔrffG strain was sensitive to some stress conditions. Interestingly, the ΔrfbBΔrffG strain displayed an altered LPS profile, autoaggregated rapidly compared to the WT and the single mutant strains and showed high N-phenylnaphthylamine (NPN) fluorescence indicating greater surface hydrophobicity. Furthermore, transcriptomic analysis identified flagellar and SPI-1 pathways to be highly downregulated in ΔrfbBΔrffG which led to impaired swimming as well as swarming motility, lower adhesion and invasion of HeLa cells. Importantly, the ΔrfbBΔrffG strain was less proficient in colonizing Peyer's patches, spleen and liver, was unable to induce pro-inflammatory cytokines and was attenuated in both the oral and intraperitoneal models of S. Typhimurium infection in mice. Overall, this study highlights the importance of rfbB and rffG in maintaining cell wall and cell membrane integrity, colony and cellular morphology, motility and virulence in S. Typhimurium.

#4

Early-Onset Pectus Excavatum Is More Likely to Be Part of a Genetic Variation.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie2024 Aug

 Potential underlying genetic variations of pectus excavatum (PE) are quite rare. Only one-fifth of PE cases are identified in the first decade of life and thus are of congenital origin. The objective of this study is to test if early-onset PE is more likely to be part of genetic variations than PE that becomes apparent during puberty or adolescence.  Children younger than 11 years who presented with PE to the outpatient clinic of the Department of Pediatric Surgery at our center between 2014 and 2020 were screened by two clinical geneticists separately. Molecular analysis was performed based on the differential diagnosis. Data of all young PE patients who already had been referred for genetic counseling were analyzed retrospectively.  Pathogenic genetic variations were found in 8 of the 18 participants (44%): 3 syndromic disorders (Catel-Manzke syndrome and two Noonan syndromes), 3 chromosomal disorders (16p13.11 microduplication syndrome, 22q11.21 microduplication syndrome, and genetic gain at 1q44), 1 connective tissue disease (Loeys-Dietz syndrome), and 1 neuromuscular disorder (pathogenic variation in BICD2 gene).  Early-onset PE is more likely to be part of genetic variations than PE that becomes apparent during puberty or adolescence. Referral for genetic counseling should therefore be considered.  NCT05443113.

#5

Isolation and molecular identification of nematode surface mutants with resistance to bacterial pathogens.

G3 (Bethesda, Md.)2023 May 02

Numerous mutants of the nematode Caenorhabditis elegans with surface abnormalities have been isolated by utilizing their resistance to a variety of bacterial pathogens (Microbacterium nematophilum, Yersinia pseudotuberculosis, and 2 Leucobacter strains), all of which are able to cause disease or death when worms are grown on bacterial lawns containing these pathogens. Previous work led to the identification of 9 srf or bus genes; here, we report molecular identification and characterization of a further 10 surface-affecting genes. Three of these were found to encode factors implicated in glycosylation (srf-2, bus-5, and bus-22), like several of those previously reported; srf-2 belongs to the GT92 family of putative galactosyltransferases, and bus-5 is homologous to human dTDP-D-glucose 4,6-dehydratase, which is implicated in Catel-Manzke syndrome. Other genes encoded proteins with sequence similarity to phosphatidylinositol phosphatases (bus-6), Patched-related receptors (ptr-15/bus-13), steroid dehydrogenases (dhs-5/bus-21), or glypiation factors (bus-24). Three genes appeared to be nematode-specific (srf-5, bus-10, and bus-28). Many mutants exhibited cuticle fragility as revealed by bleach and detergent sensitivity; this fragility was correlated with increased drug sensitivity, as well as with abnormal skiddy locomotion. Most of the genes examined were found to be expressed in epidermal seam cells, which appear to be important for synthesizing nematode surface coat. The results reveal the genetic and biochemical complexity of this critical surface layer, and provide new tools for its analysis.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC20 artigos no totalmostrando 16

2025

Zebrafish as a model for Catel-Manzke syndrome-identification and characterization of the zebrafish TGDS ortholog.

The FEBS journal
2025

A missing enzyme-rescue metabolite as cause of a rare skeletal dysplasia.

Nature
2025

Functional loss of rffG and rfbB, encoding dTDP-glucose 4,6-dehydratase, alters colony morphology, cell shape, motility and virulence in Salmonella Typhimurium.

Frontiers in microbiology
2024

Early-Onset Pectus Excavatum Is More Likely to Be Part of a Genetic Variation.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie
2023

Isolation and molecular identification of nematode surface mutants with resistance to bacterial pathogens.

G3 (Bethesda, Md.)
2022

The Pathogenesis of Pierre Robin Sequence through a Review of SOX9 and Its Interactions.

Plastic and reconstructive surgery. Global open
2021

A Homozygous Deletion of Exon 5 of KYNU Resulting from a Maternal Chromosome 2 Isodisomy (UPD2) Causes Catel-Manzke-Syndrome/VCRL Syndrome.

Genes
2020

Biallelic variants in KYNU cause a multisystemic syndrome with hand hyperphalangism.

Bone
2020

Catel-Manzke syndrome without Manzke dysostosis.

American journal of medical genetics. Part A
2020

TGDS pathogenic variants cause Catel-Manzke syndrome without hyperphalangy.

American journal of medical genetics. Part A
2017

Mutations in TGDS associated with additional malformations of the middle fingers and halluces: Atypical Catel-Manzke syndrome in a fetus.

American journal of medical genetics. Part A
2017

Short stature, unusual face, delta phalanx, and abnormal vertebrae and ribs in a girl born to half-siblings.

American journal of medical genetics. Part A
2017

Simplification of intradermal skin testing in Hymenoptera venom allergic children.

Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology
2015

Exome sequencing in a patient with Catel-Manzke-like syndrome excludes the involvement of the known genes and reveals a possible candidate.

European journal of medical genetics
2015

Catel-Manzke Syndrome: Further Delineation of the Phenotype Associated with Pathogenic Variants in TGDS.

Molecular genetics and metabolism reports
2015

Strategies to improve the performance of rare variant association studies by optimizing the selection of controls.

Bioinformatics (Oxford, England)
Ver todos os 20 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Catel-Manzke.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Catel-Manzke

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A missing enzyme-rescue metabolite as cause of a rare skeletal dysplasia.
    Nature· 2025· PMID 40836090mais citado
  2. Zebrafish as a model for Catel-Manzke syndrome-identification and characterization of the zebrafish TGDS ortholog.
    The FEBS journal· 2025· PMID 41159851mais citado
  3. Functional loss of rffG and rfbB, encoding dTDP-glucose 4,6-dehydratase, alters colony morphology, cell shape, motility and virulence in Salmonella Typhimurium.
    Frontiers in microbiology· 2025· PMID 40469742mais citado
  4. Early-Onset Pectus Excavatum Is More Likely to Be Part of a Genetic Variation.
    European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie· 2024· PMID 37100424mais citado
  5. Isolation and molecular identification of nematode surface mutants with resistance to bacterial pathogens.
    G3 (Bethesda, Md.)· 2023· PMID 36911920mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:1388(Orphanet)
  2. OMIM OMIM:302380(OMIM)
  3. MONDO:0014507(MONDO)
  4. GARD:28(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q5051865(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Catel-Manzke
Compêndio · Raras BR

Síndrome Catel-Manzke

ORPHA:1388 · MONDO:0014507
Prevalência
<1 / 1 000 000
Casos
33 casos conhecidos
Herança
Autosomal recessive
CID-10
Q87.8 · Outras síndromes com malformações congênitas especificadas, não classificadas em outra parte
CID-11
Início
Antenatal, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1844887
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades